215 related articles for article (PubMed ID: 31747890)
1. Prediction model for pneumonia in primary care patients with an acute respiratory tract infection: role of symptoms, signs, and biomarkers.
Groeneveld GH; van 't Wout JW; Aarts NJ; van Rooden CJ; Verheij TJM; Cobbaert CM; Kuijper EJ; de Vries JJC; van Dissel JT
BMC Infect Dis; 2019 Nov; 19(1):976. PubMed ID: 31747890
[TBL] [Abstract][Full Text] [Related]
2. Clinical factors, C-reactive protein point of care test and chest X-ray in patients with pneumonia: A survey in primary care.
Groeneveld GH; van de Peppel RJ; de Waal MWM; Verheij TJM; van Dissel JT
Eur J Gen Pract; 2019 Oct; 25(4):229-235. PubMed ID: 31455104
[No Abstract] [Full Text] [Related]
3. Contributions of symptoms, signs, erythrocyte sedimentation rate, and C-reactive protein to a diagnosis of pneumonia in acute lower respiratory tract infection.
Hopstaken RM; Muris JW; Knottnerus JA; Kester AD; Rinkens PE; Dinant GJ
Br J Gen Pract; 2003 May; 53(490):358-64. PubMed ID: 12830562
[TBL] [Abstract][Full Text] [Related]
4. Infection biomarkers in primary care patients with acute respiratory tract infections-comparison of Procalcitonin and C-reactive protein.
Meili M; Kutz A; Briel M; Christ-Crain M; Bucher HC; Mueller B; Schuetz P
BMC Pulm Med; 2016 Mar; 16():43. PubMed ID: 27009083
[TBL] [Abstract][Full Text] [Related]
5. Use of serum C reactive protein and procalcitonin concentrations in addition to symptoms and signs to predict pneumonia in patients presenting to primary care with acute cough: diagnostic study.
van Vugt SF; Broekhuizen BD; Lammens C; Zuithoff NP; de Jong PA; Coenen S; Ieven M; Butler CC; Goossens H; Little P; Verheij TJ;
BMJ; 2013 Apr; 346():f2450. PubMed ID: 23633005
[TBL] [Abstract][Full Text] [Related]
6. C-reactive protein and procalcitonin to discriminate between tuberculosis, Pneumocystis jirovecii pneumonia, and bacterial pneumonia in HIV-infected inpatients meeting WHO criteria for seriously ill: a prospective cohort study.
Mendelson F; Griesel R; Tiffin N; Rangaka M; Boulle A; Mendelson M; Maartens G
BMC Infect Dis; 2018 Aug; 18(1):399. PubMed ID: 30107791
[TBL] [Abstract][Full Text] [Related]
7. Procalcitonin versus C-reactive protein for predicting pneumonia in adults with lower respiratory tract infection in primary care.
Holm A; Pedersen SS; Nexoe J; Obel N; Nielsen LP; Koldkjaer O; Pedersen C
Br J Gen Pract; 2007 Jul; 57(540):555-60. PubMed ID: 17727748
[TBL] [Abstract][Full Text] [Related]
8. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.
Schuetz P; Müller B; Christ-Crain M; Stolz D; Tamm M; Bouadma L; Luyt CE; Wolff M; Chastre J; Tubach F; Kristoffersen KB; Burkhardt O; Welte T; Schroeder S; Nobre V; Wei L; Bhatnagar N; Bucher HC; Briel M
Evid Based Child Health; 2013 Jul; 8(4):1297-371. PubMed ID: 23877944
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic accuracy of C-reactive protein and procalcitonin in suspected community-acquired pneumonia adults visiting emergency department and having a systematic thoracic CT scan.
Le Bel J; Hausfater P; Chenevier-Gobeaux C; Blanc FX; Benjoar M; Ficko C; Ray P; Choquet C; Duval X; Claessens YE;
Crit Care; 2015 Oct; 19():366. PubMed ID: 26472401
[TBL] [Abstract][Full Text] [Related]
10. C-reactive protein point-of-care testing and antibiotic prescribing for acute respiratory tract infections in rural primary health centres of North Ethiopia: a cross-sectional study.
Yebyo H; Medhanyie AA; Spigt M; Hopstaken R
NPJ Prim Care Respir Med; 2016 Jan; 26():15076. PubMed ID: 26769226
[TBL] [Abstract][Full Text] [Related]
11. Biomarkers and community-acquired pneumonia: tailoring management with biological data.
Torres A; Ramirez P; Montull B; Menéndez R
Semin Respir Crit Care Med; 2012 Jun; 33(3):266-71. PubMed ID: 22718212
[TBL] [Abstract][Full Text] [Related]
12. The association of serum procalcitonin and high-sensitivity C-reactive protein with pneumonia in elderly multimorbid patients with respiratory symptoms: retrospective cohort study.
Nouvenne A; Ticinesi A; Folesani G; Cerundolo N; Prati B; Morelli I; Guida L; Lauretani F; Maggio M; Aloe R; Lippi G; Meschi T
BMC Geriatr; 2016 Jan; 16():16. PubMed ID: 26772604
[TBL] [Abstract][Full Text] [Related]
13. C-reactive protein point-of-care testing and associated antibiotic prescribing.
Minnaard MC; van de Pol AC; Hopstaken RM; van Delft S; Broekhuizen BD; Verheij TJ; de Wit NJ
Fam Pract; 2016 Aug; 33(4):408-13. PubMed ID: 27230745
[TBL] [Abstract][Full Text] [Related]
14. Point-of-care C-reactive protein testing to reduce inappropriate use of antibiotics for non-severe acute respiratory infections in Vietnamese primary health care: a randomised controlled trial.
Do NT; Ta NT; Tran NT; Than HM; Vu BT; Hoang LB; van Doorn HR; Vu DT; Cals JW; Chandna A; Lubell Y; Nadjm B; Thwaites G; Wolbers M; Nguyen KV; Wertheim HF
Lancet Glob Health; 2016 Sep; 4(9):e633-41. PubMed ID: 27495137
[TBL] [Abstract][Full Text] [Related]
15. Performance of pro-adrenomedullin for identifying adverse outcomes in community-acquired pneumonia.
España PP; Capelastegui A; Mar C; Bilbao A; Quintana JM; Diez R; Esteban C; Bereciartua E; Unanue U; Uranga A
J Infect; 2015 May; 70(5):457-66. PubMed ID: 25499199
[TBL] [Abstract][Full Text] [Related]
16. Biomarkers in lower respiratory tract infections.
Blasi F; Stolz D; Piffer F
Pulm Pharmacol Ther; 2010 Dec; 23(6):501-7. PubMed ID: 20434579
[TBL] [Abstract][Full Text] [Related]
17. Management of patients with respiratory infections in primary care: procalcitonin, C-reactive protein or both?
Meili M; Müller B; Kulkarni P; Schütz P
Expert Rev Respir Med; 2015 Oct; 9(5):587-601. PubMed ID: 26366806
[TBL] [Abstract][Full Text] [Related]
18. Procalcitonin, C-reactive protein and leukocyte count in children with lower respiratory tract infection.
Prat C; Domínguez J; Rodrigo C; Giménez M; Azuara M; Jiménez O; Galí N; Ausina V
Pediatr Infect Dis J; 2003 Nov; 22(11):963-8. PubMed ID: 14614368
[TBL] [Abstract][Full Text] [Related]
19. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial.
Christ-Crain M; Jaccard-Stolz D; Bingisser R; Gencay MM; Huber PR; Tamm M; Müller B
Lancet; 2004 Feb; 363(9409):600-7. PubMed ID: 14987884
[TBL] [Abstract][Full Text] [Related]
20. Signs and symptoms do not predict, but may help rule out acute Q fever in favour of other respiratory tract infections, and reduce antibiotics overuse in primary care.
Hackert VH; Dukers-Muijrers NHTM; Hoebe CJPA
BMC Infect Dis; 2020 Sep; 20(1):690. PubMed ID: 32957938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
